NCT01653249View on ClinicalTrials.gov

A Phase I Clinical Trial of an HPV Therapeutic Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Human Papillomavirus
Interventions
BIOLOGICAL

Vaccine consisting of four HPV-16 E6 peptides in combination with Candin®

Trial Locations (1)

72205

University of Arkansas for Medical Sciences, Little Rock

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Arkansas

OTHER

NCT01653249 - A Phase I Clinical Trial of an HPV Therapeutic Vaccine | Biotech Hunter | Biotech Hunter